Showing results (441-450 of 1,014) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|May 6, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal AdenocarcinomaNicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes, et al.Cancer Research Communications|May 8, 2024
B7-H3-Targeting Chimeric Antigen Receptors Epstein-Barr Virus-specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3-positive Solid TumorsSiok Ping Yeo, Lindsay Kua, Jin Wei Tan, et al.Cancer Research Communications|April 17, 2024
Small Extracellular Vesicles Promote Stiffness-mediated MetastasisAlexandra Sneider, Ying Liu, Bartholomew Starich, et al.Cancer Research Communications|April 17, 2024
LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination DeficiencyAditya Kulkarni, Jianli Zhou, Neha Biyani, et al.Cancer Research Communications|April 29, 2024
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal MelanomaElizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, et al.Cancer Research Communications|May 2, 2024
Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical ImplicationsJie Dai, Jia Jia, Fanshuang Zhang, et al.Cancer Research Communications|April 16, 2024
Urolithin-A Promotes CD8+ T Cell-mediated Cancer Immunosurveillance via FOXO1 ActivationPierpaolo Ginefra, Helen Carrasco Hope, Yi-Hsuan Chiang, et al.Cancer Research Communications|December 19, 2023
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic CancersJoseph L Sottnik, Madeleine T Shackleford, Sydney K Robinson, et al.Cancer Research Communications|December 21, 2023
Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 ExpressionMarta Ligero, Garazi Serna, Omar S M El Nahhas, et al.Cancer Research Communications|December 18, 2023
Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical TrialsEmily Schwarz, Brooke Benner, Lianbo Yu, et al.Pageof 102